Talbangsa, Alnasri M.

HRN: 22-25-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2022
CEFUROXIME 750MG (VIAL)
11/26/2022
12/03/2022
IV
750mg
Q8
Pneumonia
Waiting Final Action 
11/26/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/26/2022
12/02/2022
IVT
500mg
Q8
Mechanical Bowel Obstruction
Waiting Final Action 
11/28/2022
CLARITHROMYCIN 500MG (CAP)
11/28/2022
12/12/2022
PO
1 Cap
BID
H. Pylori Infection
Waiting Final Action 
11/28/2022
AMOXICILLIN 500MG CAPSULE (CAP)
11/28/2022
12/12/2022
PO
1 Cap
BID
H. Pylori Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: